EA
ABBV icon

Eudaimonia Advisors’s AbbVie ABBV Stock Holding History

Eudaimonia Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.08M Sell
16,889
-78
-0.5% -$13.4K 1.64% 13
2023
Q4 		$2.63M Sell
16,967
-182
-1% -$26.5K 1.7% 12
2023
Q3 		$2.56M Sell
17,149
-78
-0.5% -$11.5K 1.8% 10
2023
Q2 		$2.32M Sell
17,227
-191
-1% -$28K 1.56% 13
2023
Q1 		$2.78M Sell
17,418
-397
-2% -$60.7K 1.87% 9
2022
Q4 		$2.88M Sell
17,815
-57
-0.3% -$8.74K 1.95% 9
2022
Q3 		$2.4M Sell
17,872
-48
-0.3% -$6.89K 1.65% 14
2022
Q2 		$2.75M Sell
17,920
-498
-3% -$76.1K 1.89% 11
2022
Q1 		$2.99M Buy
18,418
+2,511
+16% +$365K 1.72% 9
2021
Q4 		$2.15M Buy
+15,907
New +$1.88M 1.27% 19

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Eudaimonia Advisors's ABBV Position: Q1 2024 in Review

Eudaimonia Advisors reduced its AbbVie (ABBV) stake by 0.46% in Q1 2024, selling an estimated $13.4K and leaving 16,889 shares worth $3.08M. The position accounts for 1.64% of the portfolio, ranked #13.

Eudaimonia Advisors first reported a position in ABBV in Q4 2021 and has held it in 10 quarters since. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Eudaimonia Advisors held 16,889 shares of AbbVie worth $3.08M as of Q1 2024.
  • Eudaimonia Advisors sold 78 AbbVie shares in Q1 2024, an estimated $13.4K.
  • AbbVie made up 1.64% of Eudaimonia Advisors's portfolio in Q1 2024, its #13 holding.
  • Eudaimonia Advisors first reported a position in AbbVie in Q4 2021 and has held it in 10 quarters since.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Eudaimonia Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.